Fatos interessantes

• Lundbeck Gains Amid Speculation of Antidepressant Success - Bloomberg
  

  Lundbeck Gains Amid Speculation of Antidepressant SuccessBloombergH.

• Self-Diagnosis Book: 11 Nasty Ailments You Might Have (PHOTOS) - Huffington Post (blog)
  

  Self-Diagnosis Book: 11 Nasty Ailments You Might Have (PHOTOS)Huffington Post (blog)At one point it got so bad, a doctor put me on Lexapro to battle the anxiety.

• Mylan 1Q profit rises on Lexapro and EpiPen sales - BusinessWeek
  

  Mylan 1Q profit rises on Lexapro and EpiPen salesBusinessWeekGeneric drugmaker Mylan Inc.

• New SSRI Antidepressant Approved, But Not Without Risk - Medical Daily
  

  New SSRI Antidepressant Approved, But Not Without RiskMedical DailyVilazodone is used in treating major depressive disorders and is in the same category as other SSRI drugs, such as Zoloft, Lexapro and Prozac.

• Generic competition for Lexapro/Cipralex hits Lundbeck's first-quarter - The Pharma Letter
  

  Generic competition for Lexapro/Cipralex hits Lundbeck's first-quarterThe Pharma LetterEBIT fell 32% to 882 million kroner, also shy of analysts' expectations of 895 million kroner, as the company faced generic competition for its flagship antidepressant Cipralex/Lexapro (escitalopram), which is sold by Forest Labs in the USA.